HR Execs on the Move

Eli Lilly

www.lilly.com

 
Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity, and respect for people. We make medicines that help people live longer, ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.lilly.com
  • 1 Lilly Corporate Ctr
    Indianapolis, IN USA 46285
  • Phone: 317.276.2000

Executives

Name Title Contact Details
Jorgen Rasmussen
 Associate Director Human Resources Profile
Kim Fuller
 Associate VP, Global Medical and Safety Sciences Strategy Profile
Mia Hillsman
 Associate VP, Head of Lilly/BI Alliance, US, Global & Sales Cardiometabolic Health Profile
Tyler Hill
 Senior Manager Supply Chain Profile
Kelly Ward
 Executive Director, Sales Strategy and Operations Profile

Similar Companies

Algenix

Algenix is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Indiva

Indiva is a Canadian licensed producer of premium cannabis and cannabis products, and a provider of extraction, manufacturing and refinement services.

Cadila Pharmaceuticals

Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last six decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over hundred other countries around the world.

Phenomenome Discoveries

Phenomenome Discoveries, Inc. is a Saskatoon, SK-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Unum Therapeutics

Unum is a Cambridge, MA-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. Unum has built an antibody-coupled T-cell receptor (ACTR) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic T-lymphocytes (CTLs) to kill tumor cells. In contrast to other approaches that hit a single target and treat a narrow set of tumors, Unum’s approach is not restricted by antigens and may have applications for treating many types of cancers.   Our lead program based on ACTR technology is expected to enter Phase I clinical testing soon to assess safety and efficacy in certain forms of leukemia and lymphoma. In parallel, we are actively seeking partners interested in using the ACTR technology to arm novel proprietary antibodies with a T-cell to improve their therapeutic potential. Working initially to pre-clinically validate antibody-ACTR combinations with partners, we expect to rapidly advance multiple proprietary combinations into clinical testing within the next few years.